Abstract:Background: Menopause in women marks the knot of reproductive life, and menopause is defined as the last menstrual period in a woman, but this is caused by the failure of the ovarian reserve. The average age of natural menopause in the general population of women has remained around 50–52 years. Premature ovarian insufficiency (POI) is a debilitating clinical syndrome that manifests as a decline in ovarian function in women under 40. This condition is a prominent cause of female infertility. Summary: POI is a debilitating condition that not only wreaks havoc on patients’ physical and mental well-being but also imposes substantial mental, psychological, and economic burdens, particularly on women. In addition to diminished fertility, individuals afflicted with POI face an elevated risk of developing debilitating conditions such as osteoporosis and cardiovascular disease. The etiologies of POI are highly heterogeneous, and it can be caused by spontaneous genetic defects or induced by autoimmune diseases, infections, and iatrogenic or environmental factors. Alarmingly, idiopathic POI, a subtype characterized by an unknown etiology, accounts for more than half of all POI cases. Currently, clinical interventions for POI primarily consist of hormone replacement therapy. Fertility preservation methods are cryopreservation of embryos, oocytes, and ovarian tissue. Immunological interventions, gene editing techniques, and stem cell-based therapies are being explored to unravel the diverse etiologies and underlying mechanisms of POI, thereby enabling the identification of optimal therapeutic interventions. These innovative approaches offer unprecedented opportunities to advance the field of reproductive medicine. Key Messages: The main aim of this paper was to offer a succinct summary of the latest research breakthroughs concerning the elucidation of the mechanisms governing the origin and management of POI.

Stem cell-based therapeutic potential in female ovarian aging and infertility

Stem Cell-Based Therapeutic Strategies for Premature Ovarian Insufficiency and Infertility: A Focus on Aging

An Update on Primary Ovarian Insufficiency

Current Status and Future Prospects of Stem Cell Therapy for Infertile Patients with Premature Ovarian Insufficiency

Advances in stem cell therapy for premature ovarian failure

Insights into Stem Cell Therapy for Premature Ovarian Insufficiency

Application of stem cells in premature ovarian insufficiency

Stem Cell Paracrine Signaling for Treatment of Premature Ovarian Insufficiency

Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell

The Activation of Residual Dormant Follicles by Human Chorionic Gonadotropin (HCG) in Vivo: a Novel Treatment for Premature Ovarian Insufficiency

Advances in Biomaterials and Regenerative Medicine for Primary Ovarian Insufficiency Therapy

Application of mesenchymal stem cell therapy for premature ovarian insufficiency: Recent advances from mechanisms to therapeutics

Research Progress on the Etiology and Treatment of Premature Ovarian Insufficiency

Therapeutic options for premature ovarian insufficiency: an updated review

Advances in clinical treatment of ovary aging

Ovarian Stem Cell Nests in Reproduction and Ovarian Aging.

Stem cell-derived extracellular vesicles: A novel and potential remedy for primary ovarian insufficiency

Current mechanisms of primordial follicle activation and new strategies for fertility preservation.

Female germline stem cells: aging and anti-aging

Bibliometric Analysis on Stem Cell Transplantation Treatment for Premature Ovarian Failure

Inflamm-Aging: A New Mechanism Affecting Premature Ovarian Insufficiency